Skip to main content
. 2019 Nov 30;20(23):6039. doi: 10.3390/ijms20236039
AD Alzheimer’s Disease
PD Parkinson’s Disease
MS Multiple Sclerosis
ALS Amyotrophic Lateral Sclerosis
hGMSCs human Gingival Mesenchymal Stem Cells
MOR Moringin
CBD Cannabidiol
IL-10 Interleukin 10
IL-1 Interleukin 1
IL-6 Interleukin-6
TNF-α Tumor Necrosis Factor alpha
IL6R IL-6 Receptor
TGF-β Transform Growth Factor beta
hGMSCs-MOR hGMSCs treated with MOR
hGMSCs-CBD hGMSCs treated with CBD
RT-PCR reverse transcription polymerase chain reaction
CLSM Confocal Laser Scanning Microscopy
hGMSCs-CTRL hGMSCs untreated
TNFR1 TNF receptor 1
RIPK1 Receptor Interacting Protein Kinase 1
IKK IκB kinase
IL1R1 IL-1 receptor type I
TIR Toll-IL-1-Receptor
MAPK Mitogen-Activated Protein Kinase
MAP3K3 Mitogen-Activated Protein Kinase Kinase Kinase 3
JAKs Janus kinases
TGFβR1 TGFβ Receptor type 1
TGFβR2 TGFβ Receptor type 2
PP1 Protein Phosphatase 1
PBS Phosphate Buffered Saline
MTT 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazoliumbromide